WASHINGTON (AP) — The Food and Drug Administration has approved a new implantable device to help doctors monitor patients with severe heart failure as they go about their day.
The agency cleared the CardioMEMS HF system Wednesday for patients who have been hospitalized in the previous year due to heart failure.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.